Buprenorphine has been shown to be effective for fentanyl users in the emergency room.

Published Date: 13 Mar 2023

A review of electronic medical records found similar associations between opioid-using patients who reported and did not report fentanyl use.

Read Full News

Todays Updates


FDA Grants Emergency Approval for Over-the-counter Drug to Treat Screwworm in Pets


The U.S. Food and Drug Administration on Thursday authorized the emergency use of a generic over-the-counter tablet ⁠to treat infestations caused by the New World screwworm...

Highlights in Prostate Cancer From AUA 2026


Extent of lymph node dissection, defining high-risk criteria, oral androgen deprivation therapy (ADT), and darolutamide plus ADT are among the highlights for prostate cancer management from AUA 2026.

New Imaging Agent Could Speed Detection of AD-Related Tau


A novel PET imaging agent identified AD-related tau earlier and in more patients than the currently used tracer, possibly speeding AD detection, a new study shows.

CMS Rule Misses Mark on CPAP Adherence


A Kaiser Permanente study shows some people who initially struggle with CPAP adherence still use the device at 1 year, suggesting CMS’ 90-day cutoff is too strict.

Good Outcomes with Ublituximab in First Real-World Study


Even though the real-world patients in a phase 4 study were older and heavier, ublituximab provided safety and tolerability at least comparable to that in 2 pivotal trials.

Organon Wins US Approval to Widen Use Of Arthritis Biosimilar Drug


Organon said on Wednesday the U.S. Food and Drug Administration has approved the expanded ⁠use of its arthritis drug, a biosimilar to Roche's Actemra, to treat a...

Ebola Testing Stalled in Three Congo Labs Due to Shortages, Says WHO


Three laboratories in Democratic Republic of Congo have run out of supplies to test for Ebola, the World ⁠Health Organization said, as the outbreak of the dangerous...

Todays Updates


FDA Grants Emergency Approval for Over-the-counter Drug to Treat Screwworm in Pets


The U.S. Food and Drug Administration on Thursday authorized the emergency use of a generic over-the-counter tablet ⁠to treat infestations caused by the New World screwworm...

Highlights in Prostate Cancer From AUA 2026


Extent of lymph node dissection, defining high-risk criteria, oral androgen deprivation therapy (ADT), and darolutamide plus ADT are among the highlights for prostate cancer management from AUA 2026.

New Imaging Agent Could Speed Detection of AD-Related Tau


A novel PET imaging agent identified AD-related tau earlier and in more patients than the currently used tracer, possibly speeding AD detection, a new study shows.

CMS Rule Misses Mark on CPAP Adherence


A Kaiser Permanente study shows some people who initially struggle with CPAP adherence still use the device at 1 year, suggesting CMS’ 90-day cutoff is too strict.

Good Outcomes with Ublituximab in First Real-World Study


Even though the real-world patients in a phase 4 study were older and heavier, ublituximab provided safety and tolerability at least comparable to that in 2 pivotal trials.

Organon Wins US Approval to Widen Use Of Arthritis Biosimilar Drug


Organon said on Wednesday the U.S. Food and Drug Administration has approved the expanded ⁠use of its arthritis drug, a biosimilar to Roche's Actemra, to treat a...

Ebola Testing Stalled in Three Congo Labs Due to Shortages, Says WHO


Three laboratories in Democratic Republic of Congo have run out of supplies to test for Ebola, the World ⁠Health Organization said, as the outbreak of the dangerous...

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

FDA Approves Novel Targeted Therapy for Rare Blood Cancer

2.

Electronic Sepsis Alerts; Reducing Plaques in Coronary Arteries

3.

The Predictive Power of Liquid Biopsy in Colon Cancer Outcomes Is Inconsistent.

4.

10-year study shows tomosynthesis improves breast cancer detection

5.

Adaptive SABR-Used Hypofractionated Chemoradiation Showed Good Results in NSCLC.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot